Search results
Results from the WOW.Com Content Network
aPriori Capital Partners is a private equity investment firm focused on leveraged buyout transactions. The firm was founded as an affiliate of Credit Suisse and traces its roots to Donaldson, Lufkin & Jenrette, the investment bank acquired by Credit Suisse First Boston in 2000.
After a 2017 initial public offering, WideOpenWest is publicly traded with Avista Capital Partners and Crestview Partners retaining significant stakes. [7] As of August 6, 2019 Avista Capital Partners sold their shares in the company, leaving Crestview Partners WOW's largest shareholder holding a 37% stake in the company. [8]
Goldman Sachs has historically invested capital in a variety of businesses alongside its investment banking clients. [2] In the early and mid-1980s, Goldman was a slow entrant into the financing of leveraged buyouts and junk bonds and preferred to focus on its traditional mergers and acquisitions advisory business.
CVC Capital Partners plc is a Jersey-based private equity and investment advisory firm with approximately €186 billion of assets under management [3] and approximately €157 billion in secured commitments since inception across American, European, and Asian private equity, secondaries, credit funds and infrastructure. [5]
HPS Investment Partners (HPS) is an American investment firm headquartered in New York City.The firm focuses on investments in private credit and public credit as well as private equity and real assets.
2012 – Research Organics Inc., BioReliance (a toxicology and veterinary diagnostics company); [26] BioReliance had previously been acquired by Invitrogen and subsequently sold to Avista Capital Partners. [27] 2014 – Cell Marque [28] 2015 – Combined with EMD Millipore to make MilliporeSigma. [citation needed]
Court Square Capital Partners is a private equity firm focused on leveraged buyout transactions. Court Square was originally a captive private equity firm within Citigroup known as Citigroup Venture Capital Equity Partners. Court Square's investment professionals have invested over $4.5 billion in more than 150 transactions, which have returned ...
Taconic was Acquired by H.I.G. Capital in 2019. [10] In April of that same year, the company launched TruBIOME, a platform that “enables researchers to develop models with customized microbiota profiles.” [11] In 2022, Taconic was acquired by Avista Capital Partners [12]